Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F O B Spoelstra

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Novel tools in radiotherapyF O B Spoelstra, S Senan
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approachesH Tekatli, F O B Spoelstra, M Palacios, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung CancerM I Ronden, J R van Sörnsen de Koste, C Johnson, et al.
Cell Transplantation|May 25, 2006
Subnormothermic preservation maintains viability and function in a porcine hepatocyte culture model simulating bioreactor transportM P van de Kerkhove, R Hoekstra, F C van Nooijen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2010
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidityE C J Phernambucq, F O B Spoelstra, W F A R Verbakel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Novel tools in radiotherapyF O B Spoelstra, S Senan
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approachesH Tekatli, F O B Spoelstra, M Palacios, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung CancerM I Ronden, J R van Sörnsen de Koste, C Johnson, et al.
Cell Transplantation|May 25, 2006
Subnormothermic preservation maintains viability and function in a porcine hepatocyte culture model simulating bioreactor transportM P van de Kerkhove, R Hoekstra, F C van Nooijen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2010
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidityE C J Phernambucq, F O B Spoelstra, W F A R Verbakel, et al.
Pageof 1